Generic Sweden AB (OSTO:GENI) Other Current Receivables: kr19.9 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:GENI Generic Sweden AB OSTO:GENI
89 GF Score
Price kr37.60
GF Value kr59.63
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Generic Sweden AB Other Current Receivables?

Generic Sweden AB OSTO:GENI +1.21% 89 Other Current Receivables is kr19.9 Mil as of Mar. 2026. GuruFocus rates OSTO:GENI with a GF Score™ of 89/100 and a GF Value™ of kr59.63 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Generic Sweden AB's Other Current Receivables for the quarter that ended in Mar. 2026 was kr19.9 Mil.

Generic Sweden AB's quarterly Other Current Receivables declined from Sep. 2025 (kr16.95 Mil) to Dec. 2025 (kr12.62 Mil) but then increased from Dec. 2025 (kr12.62 Mil) to Mar. 2026 (kr19.85 Mil).

Generic Sweden AB's annual Other Current Receivables increased from Dec. 2023 (kr9.58 Mil) to Dec. 2024 (kr12.22 Mil) and increased from Dec. 2024 (kr12.22 Mil) to Dec. 2025 (kr12.62 Mil).

Generic Sweden AB Other Current Receivables Related Terms

Generic Sweden AB Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Generic Sweden AB's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Generic Sweden AB Other Current Receivables Chart

Generic Sweden AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.85 8.85 9.58 12.22 12.62

Generic Sweden AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.73 15.26 16.95 12.62 19.85
OSTO:GENI
89GF Score
Generic Sweden AB OSTO:GENI
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Generic Sweden AB Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of kr19.9 Mil mean?
Generic Sweden AB (OSTO:GENI) has a Other Current Receivables of kr19.9 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Generic Sweden AB and its competitors.
Is Generic Sweden AB's Other Current Receivables too high?
Generic Sweden AB's current Other Current Receivables is kr19.9 Mil. Overall, Generic Sweden AB has a GF Score™ of 89/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Generic Sweden AB's Other Current Receivables compare to QH and SHOP?
Generic Sweden AB's Other Current Receivables of kr19.9 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Software company?
A good Other Current Receivables depends on the Software industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Generic Sweden AB and its competitors. Generic Sweden AB's current Other Current Receivables is kr19.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Generic Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Generic Sweden AB (OSTO:GENI) is currently considered Significantly Undervalued. The stock's GF Value™ is kr59.63, compared to a current price of kr37.60 — trading 36.9% below its estimated fair value. The current Other Current Receivables is kr19.9 Mil. Generic Sweden AB's overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Generic Sweden AB (OSTO:GENI), the current Other Current Receivables is kr19.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Generic Sweden AB (OSTO:GENI) Overvalued in 2026?

Based on GuruFocus' analysis, Generic Sweden AB stock appears to be undervalued. The current stock price of kr37.60 is trading 36.9% below its estimated GF Value™ of kr59.63. GuruFocus considers Generic Sweden AB to be Significantly Undervalued.

Key valuation signals for OSTO:GENI:

  • Other Current Receivables: kr19.9 Mil
  • GF Value™: kr59.63 vs. price of kr37.60 (36.9% below fair value)
  • GF Score™: 89/100 with 1 warning sign

No single metric tells the full story. See the OSTO:GENI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Generic Sweden AB Business Description

Address Hangovagen 18, Stockholm, SWE, 115 41
Generic Sweden AB is a technology company providing high-tech messaging services for all applications. The company offers a platform for digital communication services that can be integrated into customers' internal or external communication flow. The services are provided through a Communication Platform as a Service (CPaaS) model. Generic's customers are found in all areas and with a special position in alarms and security, care and e-health as well as e-commerce and logistics.
89GF Score

Get the complete analysis for OSTO:GENI

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr37.60
Price
kr59.63
GF Value